These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 708008)

  • 21. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
    Bergan T; Thorsteinsson SB; Steingrimsson O
    Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics of temocillin in patients with normal and impaired renal function.
    Boelaert J; Daneels R; Schurgers M; Lambert AM; Van Landuyt HW; Mellows G; Wolf J; Swaisland AJ
    J Antimicrob Chemother; 1983 Apr; 11(4):349-56. PubMed ID: 6853404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP; Borsa F; Godin M
    J Antimicrob Chemother; 1983 Jul; 12(1):47-58. PubMed ID: 6619046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous azlocillin kinetics in patients on long-term hemodialysis.
    Aletta JM; Francke EF; Neu HC
    Clin Pharmacol Ther; 1980 Apr; 27(4):563-6. PubMed ID: 7357815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azlocillin pharmacokinetics in patients with cystic fibrosis.
    Bosso JA; Saxon BA; Herbst JJ; Matsen JM
    Antimicrob Agents Chemother; 1984 May; 25(5):630-2. PubMed ID: 6732230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.
    Frimodt-Möller N; Maigaard S; Toothaker RD; Bundtzen RW; Brodey MV; Craig WA; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1980 Apr; 17(4):599-607. PubMed ID: 6446877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of the new broad spectrum penicillin CP-33994-2.
    Bergan T; Brodwall EK; Orjavik O
    Arzneimittelforschung; 1980; 30(7):1144-7. PubMed ID: 7191297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of azlocillin in neonates.
    Sitka U; Weingärtner L; Patsch R; Richter I
    Chemotherapy; 1980; 26(3):171-6. PubMed ID: 7363714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the excretion of azlocillin with bronchial secretion in children (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter I; Thiemann HH
    Arzneimittelforschung; 1979; 29(12a):1952-4. PubMed ID: 543898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azlocillin kinetics during extracorporeal haemodialysis and peritoneal dialysis.
    Whelton A; Stout RL; Delgado FA
    J Antimicrob Chemother; 1983 May; 11 Suppl B():89-95. PubMed ID: 6619036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with azlocillin in complicated urinary tract infections.
    Alfthan O; Renkonen OV; Ohlsson H
    Arzneimittelforschung; 1979; 29(12a):1979-81. PubMed ID: 543906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azlocillin serum levels on repetitive dosage in patients with normal and abnormal renal function.
    Wenk M; Follath F
    Chemotherapy; 1986; 32(3):205-8. PubMed ID: 3709269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic studies of azlocillin, mezlocillin, cephalothin and sisomicin in rabbits.
    Dzierzanowska D; Patzer J; Jeljaszewicz J
    Infection; 1982; 10 Suppl 3():S217-20. PubMed ID: 6218118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis.
    Kosmidis J; Doundoulaki P; Stathakis C; Zerefos N; Bounia A; Daikos GK
    Arzneimittelforschung; 1979; 29(12a):1960-2. PubMed ID: 543901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Materno-fetal transfer of azlocillin.
    Kafetzis DA; Brater DC; Fanourgakis JE
    J Antimicrob Chemother; 1983 Aug; 12(2):157-62. PubMed ID: 6619053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temocillin elimination in patients with varying degrees of renal failure.
    Wright N; Wise R; Price JD
    J Antimicrob Chemother; 1983 May; 11(5):481-4. PubMed ID: 6874633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection.
    Roth S; Naber K; Scheer M; Gruenwaldt G; Lange H
    Eur J Clin Pharmacol; 1976 Sep; 10(5):357-65. PubMed ID: 789084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetics of Azlocillin in premature and newborn infants (author's transl)].
    Heimann G; von Heereman B; Gladtke E
    Arzneimittelforschung; 1979; 29(12a):1949-51. PubMed ID: 543897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.